BGB-8035

• Description :

  BGB-8035 is an orally available, selective and potent BTK inhibitor with antitumor activity that inhibits BTK, TEC and EGFR.BGB-8035 is used in the study of tumors and autoimmune diseases.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  453.53

• Molecular Formula :

  C24H31N5O4

• Notes :

  Research use only, not for human use.

• Receptor :

  BTK | EGFR

• CAS Number :

  2283349-24-4